| Authors: |
Cecchi M; Cognision, KY, USA. Electronic address: mcecchi@cognision.com., Adachi M; Astellas Pharma, CA, USA., Basile A; Merck & Co., Inc., Kenilworth, NJ, USA., Buhl DL; Takeda Pharmaceuticals, MA, USA., Chadchankar H; Novartis, MA, USA., Christensen S; Lundbeck, Denmark., Christian E; Gilgamesh Pharmaceuticals, NY, USA., Doherty J; Sage Therapeutics, MA, USA., Fadem KC; Cognision, KY, USA., Farley B; Sage Therapeutics, MA, USA., Forman MS; Passage Bio, PA, USA., Honda S; Astellas Pharma, CA, USA., Johannesen J; Sage Therapeutics, MA, USA., Kinon BJ; Cyclerion Therapeutics, MA, USA., Klamer D; Anavex Life Sciences Corp., NY, USA., Marino MJ; Merck & Co., Inc., Kenilworth, NJ, USA., Missling C; Anavex Life Sciences Corp., NY, USA., O'Donnell P; Sage Therapeutics, MA, USA., Piser T; Onsero Therapeutics, MA, USA., Puryear CB; Praxis Precision Medicines, MA, USA., Quirk MC; Sage Therapeutics, MA, USA., Rotte M; Novartis, MA, USA., Sanchez C; Alkermes, MA, USA., Smith DG; Alkermes, MA, USA., Uslaner JM; Merck & Co., Inc., Kenilworth, NJ, USA., Javitt DC; Columbia University, NY, USA., Keefe RSE; VeraSci, NC, USA., Mathalon D; University of California, San Francisco, CA, USA., Potter WZ; Independent Consultant, Philadelphia, PA, USA., Walling DP; CenExel Research, USA., Ereshefsky L; CenExel Research, USA; University of Texas Health Science Center at San Antonio, TX, USA. |
